TG and myalgic encephalomeyelitis/chronic fatigue syndrome: Treatments proposed or trialed for both of these conditions have targeted (a) the correction of suppressed endocrine axes, and/or (b) inflammation, O&NS, and/or low thyroid hormone function. Treatment trials to date have been limited in scope and number; both prolonged critical illness and ME/CFS remain unsolved conditions.